Revenue
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
National Health Investors Inc (NHI)
Price$70.88Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.1M | $54.4M | $48.8M | $35.8M | $0 | $0 | $318.1M | $294.6M | $278.7M | $248.5M | $228.9M | $177.5M | $117.8M | $93.3M | $83.7M | $82.6M | $62.8M | $56.9M |
| Operating expenses | $239.0M | $211.9M | $200.9M | $241.9M | $216.1M | $161.8M | $156.8M | $139.5M | $127.2M | $129.7M | $102.2M | $74.4M | $41.8M | $25.4M | $24.2M | $21.1M | $14.1M | $12.3M |
| Operating income | $190.6M | $188.5M | $178.5M | $132.8M | — | — | — | — | — | — | $150.3M | $103.1M | $79.5M | $72.8M | $69.8M | $61.8M | $48.7M | $44.6M |
| Operating margin | 238.05% | 346.37% | 365.69% | 370.90% | — | — | — | — | — | — | 65.65% | 58.05% | 67.47% | 78.05% | 83.37% | 74.82% | 77.48% | 78.39% |
| EBITDA | $275.7M | $264.2M | $259.9M | $178.7M | — | — | — | — | — | — | $203.4M | $141.1M | — | — | — | — | — | — |
| EBITDA margin | 344.32% | 485.48% | 532.42% | 499.31% | — | — | — | — | — | — | 88.86% | 79.51% | — | — | — | — | — | — |
| Net income | $142.2M | $138.0M | $135.7M | $66.4M | $111.8M | $185.1M | $160.5M | $154.3M | $159.4M | $151.5M | $148.9M | $101.6M | $106.2M | $90.7M | $81.1M | $69.4M | $64.2M | $57.5M |
| Net profit margin | 177.58% | 253.55% | 277.93% | 185.50% | — | — | 50.45% | 52.39% | 57.19% | 60.99% | 65.02% | 57.24% | 90.12% | 97.23% | 96.89% | 84.07% | 102.29% | 101.00% |
| Basic EPSper basic share | $3.03 | $3.14 | $3.13 | $1.48 | $2.45 | $4.14 | $3.70 | $3.68 | $3.90 | $3.88 | $3.96 | $3.04 | $3.74 | $3.26 | $2.93 | $2.51 | $2.33 | $2.08 |
| Diluted EPSper diluted share | $3.02 | $3.13 | $3.13 | $1.48 | $2.44 | $4.14 | $3.67 | $3.67 | $3.87 | $3.87 | $3.95 | $3.04 | $3.74 | $3.26 | $2.92 | $2.50 | $2.32 | $2.07 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
ADAMS ROBERT G | 566.55K |
Mendelsohn D. Eric | 133.32K |
SWAFFORD CHARLOTTE A | 127.36K |
Gaines Kristin Sallee | 73.76K |
PASCOE KEVIN CARLTON | 73.08K |
Spaid John L | 56.29K |
MCCABE ROBERT A JR | 44.16K |
Travis David L | 40.57K |
COLDEN TRACY M J | 12.86K |
Todd Candice W | 2.56K |
Blankenship Elizabeth Jackson | 2.42K |
Chapin Robert | 1.27K |
Donohue Lilly | 1.27K |
ADAMS W ANDREW | — |
WEBB ROBERT T | — |
Jobe James R | — |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026Form 4 | MCCABE ROBERT A JRDirector | BuyShares Of Common Stock | 890 | $71.65 | $63.8K | 44.2K |
| Jun 5, 2026Form 4 | Mendelsohn D. EricCEO and President | BuyCommon Stock | 1.5K | $68.84 | $103.3K | 133.3K |